Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on invested capital (ROIC) high or low?
The return on invested capital (ROIC) of -343.55% is 75% below its 5-year average of -195.88%, near the high end of its 5-year range (-3263.37%–-18.40%).
As of the fiscal period ended Tuesday, June 30, 2026. 37.54% below its 12-month average of -249.79%.
Trailing-twelve-month return on invested capital at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): -343.55%.
RETURN ON INVESTED CAPITAL (ROIC)
-343.55%
RETURN ON INVESTED CAPITAL (ROIC) AVG TTM
-249.79%
RETURN ON INVESTED CAPITAL (ROIC) AVG 3Y
-253.41%
RETURN ON INVESTED CAPITAL (ROIC) AVG 5Y
-195.88%
RETURN ON INVESTED CAPITAL (ROIC) AVG 10Y
-151.47%
RETURN ON INVESTED CAPITAL (ROIC) AVG 15Y
N/A
RETURN ON INVESTED CAPITAL (ROIC) AVG 20Y
N/A
CURRENT VS TTM AVG
-37.54%
CURRENT VS 3Y AVG
-35.57%
CURRENT VS 5Y AVG
-75.39%
CURRENT VS 10Y AVG
-126.81%
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
SECTOR MEDIAN · HEALTHCARE
-35.64%
median of 838 covered companies
CURRENT VS SECTOR MEDIAN
-863.81%
vs the sector median at left
Decoy Therapeutics Inc.
Market Cap
$840882.00
Return on Invested Capital (ROIC)
-343.55%
TTM Avg
-249.79%
3Y Avg
-253.41%
5Y Avg
-195.88%
Market Cap
$843637.00
Return on Invested Capital (ROIC)
-78.01%
TTM Avg
-90.63%
3Y Avg
-141.82%
5Y Avg
-116.81%
Market Cap
$834466.00
Return on Invested Capital (ROIC)
N/A
TTM Avg
-3.54%
3Y Avg
-13.19%
5Y Avg
-11.55%
Market Cap
$849293.00
Return on Invested Capital (ROIC)
-77.55%
TTM Avg
-118.09%
3Y Avg
-161.88%
5Y Avg
-137.96%
Market Cap
$880215.00
Return on Invested Capital (ROIC)
-18.56%
TTM Avg
-21.38%
3Y Avg
-25.71%
5Y Avg
-46.44%
Market Cap
$893920.00
Return on Invested Capital (ROIC)
N/A
TTM Avg
-416.12%
3Y Avg
-338.16%
5Y Avg
-243.59%
Market Cap
$742225.00
Return on Invested Capital (ROIC)
N/A
TTM Avg
-19.74%
3Y Avg
-21.30%
5Y Avg
-19.67%
Market Cap
$663982.00
Return on Invested Capital (ROIC)
4.47%
TTM Avg
-1129.41%
3Y Avg
-780.32%
5Y Avg
-986.52%
Market Cap
$1.02M
Return on Invested Capital (ROIC)
-59.81%
TTM Avg
-3.58%
3Y Avg
-5.96%
5Y Avg
-5.96%
| NAME | MARKET CAP | RETURN ON INVESTED CAPITAL (ROIC) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Decoy Therapeutics Inc. (DCOY) | $840882.00 | -343.55% | -249.79% | -253.41% | -195.88% |
| Bone Biologics Corporation (BBLG)vs › | $843637.00 | -78.01% | -90.63% | -141.82% | -116.81% |
| Ridgetech, Inc. (RDGT)vs › | $834466.00 | N/A | -3.54% | -13.19% | -11.55% |
| Bluejay Diagnostics, Inc. (BJDX)vs › | $849293.00 | -77.55% | -118.09% | -161.88% | -137.96% |
| Sunshine Biopharma, Inc. (SBFM)vs › | $880215.00 | -18.56% | -21.38% | -25.71% | -46.44% |
| GlucoTrack, Inc. (GCTK)vs › | $893920.00 | N/A | -416.12% | -338.16% | -243.59% |
| China SXT Pharmaceuticals, Inc. (SXTC)vs › | $742225.00 | N/A | -19.74% | -21.30% | -19.67% |
| CDT Equity Inc. (CDT)vs › | $663982.00 | 4.47% | -1129.41% | -780.32% | -986.52% |
| Aspire Biopharma Holdings, Inc. (ASBP)vs › | $1.02M | -59.81% | -3.58% | -5.96% | -5.96% |
| Clearmind Medicine Inc. (CMND)vs › | $1.11M | -60.41% | -162.02% | -321.37% | -223.75% |
ROIC
-343.5%
ROE
-334.4%
ROIC = NOPAT / Invested Capital, where NOPAT = Operating Income × (1 − effective tax rate) and Invested Capital = Total Assets − (Current Liabilities − Short-Term Debt)
Return on invested capital measures the after-tax operating return a company earns on the capital invested in the business. TGMCharts computes it from reported statements: trailing-twelve-month operating income after tax, over invested capital at the latest balance sheet — total assets less the non-interest-bearing current liabilities (payables, accruals, deferred revenue) that fund them; short-term debt stays in the capital base. The tax rate is the period's own effective rate (income tax ÷ pretax income), capped at 45%; when pretax income is zero or negative, or the tax line is a net benefit, no tax is deducted — the operating figure is shown untaxed rather than adjusted by an assumed rate. Not shown for banks, insurers or funds.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON INVESTED CAPITAL (ROIC) |
|---|---|
| 2026-06-30 | -343.55% |
| 2026-03-31 | -339.89% |
| 2025-12-31 | -214.20% |
| 2025-09-30 | -101.51% |
| 2025-03-31 | -3263.37% |
| 2024-12-31 | -330.78% |
| 2024-09-30 | -160.33% |
| 2024-06-30 | -283.83% |
| 2024-03-31 | -245.48% |
| 2023-12-31 | -231.22% |
| 2023-09-30 | -281.26% |
| 2023-06-30 | -255.44% |
| 2023-03-31 | -400.78% |
| 2022-12-31 | -221.24% |
| 2022-09-30 | -124.26% |
| 2022-06-30 | -60.76% |
| 2022-03-31 | -51.25% |
| 2021-12-31 | -33.09% |
| 2021-09-30 | -24.44% |
| 2021-06-30 | -18.40% |
| 2021-03-31 | -14.38% |
| 2020-12-31 | -33.61% |
| 2020-09-30 | -37.02% |
| 2020-06-30 | -58.81% |
| 2020-03-31 | -52.52% |
| 2019-12-31 | -85.37% |
| 2019-09-30 | -89.86% |
| 2019-06-30 | -136.53% |
| 2019-03-31 | -220.46% |
| 2018-12-31 | -237.80% |
| 2018-09-30 | -254.71% |
| 2018-06-30 | -259.98% |
| 2018-03-31 | -158.18% |
| 2017-12-31 | -119.15% |
| 2017-09-30 | -95.53% |
| 2017-06-30 | -80.60% |
| 2017-03-31 | -73.70% |
| 2016-12-31 | -67.23% |
| 2016-09-30 | -60.32% |
| 2016-06-30 | -49.80% |
| 2016-03-31 | -39.06% |
| 2015-12-31 | -31.68% |
| 2015-09-30 | -21.62% |
| 2015-06-30 | -14.38% |
| 2015-03-31 | -9.23% |
